Skip to content
ITIF Logo
ITIF Search

Publications: Meghan Ostertag

June 29, 2026

Fact of the Week: 13 Percent of NIH Researchers Reported That Their Labs Lost Researchers to Other Countries Due to Funding Changes

In a survey of 1,000 U.S. researchers supported by the National Institutes of Health (NIH), 13 percent said that their labs had lost researchers to other countries as a result of NIH funding changes, while 14 percent reported that immigration policies forced scientists, students, and postdocs to turn down offers to work in NIH-supported labs.

June 29, 2026

China’s Burgeoning Biopharmaceutical Competitiveness Demands a US Response

China has become an increasingly capable competitor in the global biopharmaceutical industry. To remain competitive, the United States should double down on policies to ensure that it offers the world’s leading environment to support private sector life sciences innovation.

June 24, 2026

Economic Consequences of Section 232 Tariffs on Semiconductor Imports

The Trump administration has imposed tariffs on semiconductor imports on national security grounds under Section 232 of the Trade Expansion Act. These tariffs would raise ICT prices and thereby lower ICT consumption and capital stocks, which would reduce economic growth and lower Americans’ living standards.

June 22, 2026

Fact of the Week: In 2026, One-Third of Emergency Calls Will Be Made by Smart Devices

Experts believe that in 2026, smart devices, including smart watches, fitness trackers, and digital assistants, will trigger one-third of all emergency calls.

June 15, 2026

Fact of the Week: Chinese Firms Received 3 to 8 Times As Many Subsidies Between 2005 and 2024 As Competitors in OECD Countries

Between 2005 and 2024, Chinese firms received approximately 3 to 8 times more subsidies as competitor firms in the Organization for Economic Cooperation and Development.

June 8, 2026

Fact of the Week: America’s Pharmaceutical Sector Supports 5 Million Jobs and Contributes $1.65 Trillion to Economic Output

The biopharmaceutical industry generated over $800 billion in direct output in the United States in 2022, and indirectly supported an additional $850 billion in output through its suppliers and other downstream sectors, for a total of $1.65 trillion in economic output.

June 8, 2026

Taxing AI Compute Would Be a Mistake

Proposals to tax AI computing power are proliferating as concerns about AI grow. But an AI compute tax would slow productivity growth, drive investment abroad, and do little to protect workers or preserve the tax base.

June 4, 2026

Section 232 Semiconductor Tariffs Could Undermine US Economic Growth

Broad semiconductor tariffs may aim to strengthen U.S. national security, but could ultimately weaken U.S. technological leadership. Higher chip costs could raise consumer prices while slowing investment in the AI infrastructure that drives future growth.

June 1, 2026

Fact of the Week: Eliminating Cancer Deaths Would Generate $186 Trillion in Total Economic Benefits Over a 35-Year Period

If cancer deaths were to be fully eliminated by 2030, over the subsequent 35 years, 30.7 million deaths would be averted, saving 380 million years of life. These additional years of life would also yield substantial economic benefits, as each year of life generates economic value, increased productivity, and tax revenue.

June 1, 2026

Targeted Pressure: How Chinese Manufacturing Competition Impacts US States

Chinese industrial policy is reshaping global manufacturing and impacting every U.S. state. The result is growing risk to American industry, jobs, and national security.

Back to Top